FDA Launches the Global Reliance Disclosure Program to Expand Patient Access to Medicines Worldwide
FDA today announced the Global Reliance Disclosure Program (GRDP), a landmark initiative that will fundamentally transform how the FDA's regulatory drug and biologic approval decisions are leveraged by health authorities around the world.
comments(0)
5-min edit window · permanent after that